The agency might dissuade patients from participating in a crucial part of our research-and-development system.

New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive treatments—such as monoclonal antibodies—sooner.

The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, ...

Augurex’s Spinestat diagnostic test earned the FDA’s breakthrough device designation. Spinestate is a 14-3-3eta autoantibody multiplex immunoassay test for diagnosing axial spondyloarthritis, ...

A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy drugs has missed its main goal.

Breaking news updates, resources and developments about the coronavirus, also known as COVID-19, and its effects on Hawaii, the nation and the world.

Dear Savvy Senior, With a longtime vaccine critic leading the nation’s health departments, can you give me updated ...

NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...

The legislation itself hasn't yet been made public. But Mastriano said it would ban coronavirus vaccine requirements for ...

The INSTI® HIV Self Test delivers highly accurate results in 60 seconds or less, the fastest home-use HIV rapid test available. FDA-approved and ready for U.S. consumers, providing a private and ...

Elecsys’ approval could help boost the uptake of currently approved Alzheimer’s disease therapies, including Biogen’s Eisai-partnered Leqembi, with CEO Chris Viehbacher recently noting that such ...

Trump's physician, Sean Barbabella, shared news of the president's COVID vaccination in a letter to White House press secretary Karoline Leavitt.